AI assistant
InspireMD, Inc. — Director's Dealing 2016
Jul 11, 2016
34187_dirs_2016-07-11_e055ceac-e333-4a47-8928-14b45b333c18.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2016-07-07
Reporting Person: BARER SOL J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-07-07 | Series B Convertible Preferred Stock | $0.33 | P | 33333 | Acquired | 2021-07-07 | Common Stock (5833275) | Direct |
| 2016-07-07 | Warrants to Purchase Common Stock | $0.20 | P | 3333300 | Acquired | 2021-07-07 | Common Stock (3333300) | Direct |
Footnotes
F1: Consists of 3,333,300 shares of Common Stock issuable upon conversion of the Preferred Stock at the conversion price of $0.33 per share and the stated value of $33 and payment of all dividends accrued on the Preferred Stock in an aggregate of 2,499,975 shares of Common Stock upon conversion of the Preferred Stock.
F2: Each share of Preferred Stock was accompanied by a Warrant to purchase 100 shares of Common Stock at an exercise price of $0.20 per share of Common Stock. Each share of Preferred Stock and accompanying Warrant to purchase Common Stock was acquired at an aggregate price of $33.00.